Overview
Hunter J. Shkolnik is an esteemed and dedicated attorney who focuses on the trials of significant personal injury cases, primarily in the area of drug, automobile, aviation-related, and heavy truck product liability litigation. As an esteemed
attorney, he leads the discovery and trial teams of various mass tort pharmaceutical and medical device litigations for the firm.
He is also active in managing national litigation and plaintiff litigation groups including the American Association of Justice’s Actos Litigation Group.
Mr. Shkolnik is currently serving as a chairman, leader, or court-appointed representative on Plaintiff Steering Committees in various drug and other mass torts. Additionally, Mr. Shkolnik has also held officer positions in the New York State Trial Lawyers, Nassau County Bar Association and Committee Chair positions in ATLA Health Care Finance Litigation Group, Orthopedic Implant Litigation Group, AAJ Breast Cancer Litigation Group, Co-Chair AAJ Heart Device Litigation Group, and the Chair of the Medtronic ICD and CRTD Litigation Sub Group.
Hunter is a founding board member and Vice President of the Trial Lawyers of Puerto Rico (TLPR), a trade association bringing together top trial lawyers to share expertise, build partnerships,
and to add value to the local Puerto Rico community.
Mr. Shkolnik has also lectured and organized seminars on issues involving Guidant, Medtronic, and St. Jude pacemakers; ICD and lead wire recall science and litigation; cardiac device product liability litigation; class action topics such as Ethics of Mass Tort Settlements, Lone Pine, State Federal Coordination and Preemption; and has — on multiple occasions — lectured on the science related to various pharmaceuticals. He recently returned as a featured speaker at the 2nd Annual Mass Torts Puerto Rico (MTPR) Conference.
He is a legal and political news analyst with extensive experience in areas such as civil and criminal law as well as election-related issues.
Other Experience
- Napoli Bern Ripka Shkolnik LLP
- Rheingold, Valet, Rheingold, Shkolnik & McCartney
Recent Cases
*Results May Vary Depending On Your Particular Facts and Legal Circumstances*
$12.5 Billion Settlement with 3M Company
Napoli Shkolnik, along with Plaintiffs’ Co-Lead and Interim Class Counsel, is proud to announce a $12.5 billion settlement with 3M Company in the ongoing multi-district litigation over the contamination of drinking water with toxic per- and polyfluoroalkyl substances (“PFAS”) resulting from the widespread use of aqueous film-forming foam (“AFFF”). This historic class action settlement agreement resolves the claims of Public Water Systems across the country that have been impacted by actual or threatened contamination of their water systems with PFAS.
This proposed class settlement is the result of many months of negotiations between the parties and is subject to approval by Judge Richard M. Gergel, who was assigned in December 2018 to oversee the ongoing MDL proceedings in the United States District Court for the District of South Carolina.
$1.185 Billion Settlement with Dupont, Chemours, Corteva
Napoli Shkolnik is pleased to announce a major breakthrough in the pursuit of justice for water providers and their communities affected by PFAS contamination in the United States. Working diligently alongside our co-leads, we have successfully settled the material terms with defendants DuPont, Chemours, and Corteva regarding their responsibility for the PFAS contamination of public water systems and the associated costs of treatment.
Under the terms of the agreement, DuPont, Chemours, and Corteva acknowledge their role in the PFAS contamination crisis and must provide financial compensation for the cost of treatment necessary to address the contamination their ‘forever chemicals’ caused.
$600 Million Settlement in the Flint Water Litigation
Napoli Shkolnik PLLC, as co-liaison and negotiating counsel in the Flint Water Litigation, along with interim class counsel and representatives of the State of Michigan Attorney General’s office, reached a landmark wide- reaching $600 million settlement with the State of Michigan, Michigan Department of Environmental Quality (now the Michigan Department of Environment, Great Lakes, and Energy), City of Flint, former Governor Richard Snyder, Governor Gretchen Whitmer, and several other State and City employees in the Flint Water Crisis Litigation on behalf of the citizens of Flint, Michigan.
$320 Million Opioid Settlement
This landmark settlement was reached on behalf of Cuyahoga County (Ohio), one of the bellwether plaintiffs in the National Opioid Litigation, against four of the key players responsible for the opioid epidemic.
$650 Million Ruling in National Pharmacy Chain Opioid Trial
U.S. District Court for Northern Ohio Judge Dan Aaron Polster ruled that CVS, Walgreens and Walmart must pay over $650 million over 15 years and set up an abatement program to Lake and Trumbull counties. The ruling is the first by a federal judge that assigns a monetary amount against pharmacy chains for their role in the opioid epidemic.
The funds will be used in programs to address the fallout from opioid abuse the defendant’s marketing of opioids caused.
Jury Verdict in New York Opioid Jury Trial
The jury held Teva Pharmaceuticals USA, Inc., Cephalon, Inc., Actavis, LLC, Actavis Pharma, Inc., Watson Laboratories, Inc., and Anda, Inc. responsible for causing a public nuisance.
(Napoli Shkolnik is Counsel to Nassau County.)
$1.1 Billion Settlement: New York Opioid Jury Trial
This settlement was reached with the three largest drug distributors, AmerisourceBergen, Cardinal Health and McKesson, in the first opioid jury trial.
(Napoli Shkolnik is Counsel to Nassau County.)
$50 Million Settlement: New York Opioid Jury Trial
Endo Pharmaceutical agreed to this settlement to end their involvement in the NY opioid jury trial, where the company was accused of its role in the opioid epidemic.
(Napoli Shkolnik is Counsel to Nassau County.)
$320 Million Opioid Settlement
This landmark settlement was reached on behalf of Cuyahoga County (Ohio), one of the bellwether plaintiffs in the National Opioid Litigation, against four of the key players responsible for the opioid epidemic.
Jeffrey Boatman, et ano. v. Uniflight, LLC
$24.1 Million Verdict in favor of helicopter crash victim
$650 Million Pharmaceutical Settlement
In re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation: clients participated in the $650 Million Pradaxa Master Settlement Program for compensation for their bleeding injuries caused by the blood thinner Pradaxa.
Awards & Honors
American Association for Justice – Leaders Forum
Best Law Firms in New York, U.S. News & World Report, 2019
The Best Lawyers in America: Mass Tort Litigation / Class Actions – Plaintiffs
The Best Lawyers in America©
The Best Lawyers in America: Product Liability Litigation – Plaintiffs
Lawdragon Leading Plaintiff Consumer Lawyers, 2023
Litigation Counsel of America, Fellow Marquis Who’s Who®, 2018
The National Trial Lawyers, Aviation Trial Lawyers – Top 10
New York Super Lawyers®: 2006 – 2023
Professional Affiliations
• American Association of Justice (AAJ), PFC Water Contamination Group, Co-Chair
• American Association of Justice (AAJ), The Actos Bladder Cancer Litigation Group, Co-Chair
• American Association of Justice (AAJ), Past Vice-Chairman, Healthcare Finance Litigation Group
• American Association of Justice (AAJ) Health Orthopedic Implant Litigation Group, Past Vice-Chairman, Science Committee Director
• American Association of Justice (AAJ), Past Chairman, Health Breast Cancer Litigation Group
• American Association of Justice (AAJ), Co-Chair, Health Heart Device Litigation Group
• Law360’s 2020 Editorial Advisory Boards: Trials
• Law360’s 2021 Product Liability Advisory Board
• Long Island Affiliate of the NYSTLA, Past President
• Nassau County Bar Association, Past Vice-Chairman, Medical-Legal Committee
• New York State Trial Lawyers (NYSTLA), Board of Directors; Past Secretary, Assistant Treasurer, and Treasurer
• Suffolk County Bar Association
• Trial Lawyers of Puerto Rico, Vice President
